Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00019955 · ClinicalTrials.gov registry record · Phase 2
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00019955: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).
NCT00019955 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00019955, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiofrequency interstitial tissue ablation may kill tumor cells by heating tumors to several degrees above body temperature. PURPOSE: This phase II trial is studying radiofrequency interstitial tissue ablation to see how well it works in treating patients with localized renal cell carcinoma (kidney cancer).
Interventions
- PROCEDURE laparoscopic surgery
- PROCEDURE radiofrequency ablation
- PROCEDURE thermal ablation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-03 |
| Phase | Phase 2 |
What the finished NCT00019955 record still lists
NCT00019955 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which laparoscopic surgery is the first listed.
NCT00019955 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00019955 about?
NCT00019955 is a clinical study titled "Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)". RATIONALE: Radiofrequency interstitial tissue ablation may kill tumor cells by heating tumors to several degrees above body temperature. PURPOSE: This phase II trial is studying radiofrequency interstitial tissue ablation to see how well it works in treating patients with localized renal cell carci...
What is the current status of trial NCT00019955?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-03.
What interventions are being tested in trial NCT00019955?
The interventions under investigation include: laparoscopic surgery (PROCEDURE), radiofrequency ablation (PROCEDURE), thermal ablation therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00019955?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia